CIM REAL ESTATE FINANCE TRUST, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CIM REAL ESTATE FINANCE TRUST, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $416.00M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $483.90M | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $568.86M | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | $452.15M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $365.73M | Mar 28, 2024 |
| FY2020 | Dec 31, 2020 | $76.98M | Mar 31, 2021 |
| FY2020 | Sep 30, 2020 | $72.64M | Mar 31, 2021 |
| FY2020 | Jun 30, 2020 | $67.30M | Mar 31, 2021 |
| FY2020 | Mar 31, 2020 | $74.01M | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | $93.09M | Mar 31, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.36M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | ($292.30M) | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $28.08M | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | $143.80M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $86.49M | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | ($23.52M) | Mar 28, 2023 |
| FY2020 | Dec 31, 2019 | $162.57M | Mar 31, 2021 |
| FY2020 | Sep 30, 2019 | $2.54M | Mar 31, 2021 |
| FY2020 | Jun 30, 2019 | $8.97M | Mar 31, 2021 |
| FY2020 | Mar 31, 2019 | $8.82M | Mar 31, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $323.21M | Mar 28, 2023 |
| FY2022 | Dec 31, 2021 | $174.68M | Mar 28, 2023 |
| FY2022 | Dec 31, 2020 | $45.44M | Mar 28, 2023 |
| FY2021 | Dec 31, 2019 | $289.18M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $135.33M | Mar 31, 2021 |
| FY2017 | Dec 31, 2017 | $37.90M | Mar 30, 2018 |
| FY2017 | Sep 30, 2017 | $37.76M | Mar 30, 2018 |
| FY2017 | Jun 30, 2017 | $38.76M | Mar 30, 2018 |
| FY2017 | Mar 31, 2017 | $38.78M | Mar 30, 2018 |
| FY2017 | Dec 31, 2016 | $35.04M | Mar 30, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $136.01M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $161.25M | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $223.78M | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | $178.70M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $148.17M | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | $110.57M | Mar 28, 2023 |
| FY2021 | Dec 31, 2019 | $193.53M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $205.84M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $198.93M | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $192.30M | Mar 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.10B | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $5.20B | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $6.45B | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | $7.13B | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $6.96B | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | $4.46B | Mar 28, 2023 |
| FY2020 | Dec 31, 2019 | $3.67B | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $4.62B | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $4.73B | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $4.62B | Mar 30, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.18B | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $3.26B | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $4.01B | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $4.51B | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $4.26B | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $2.26B | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.70B | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.62B | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.57B | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $2.36B | Mar 30, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.75B | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $1.77B | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $2.27B | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.46B | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $2.53B | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $2.20B | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.79B | Mar 31, 2021 |
| FY2020 | Dec 31, 2018 | $1.82B | Mar 31, 2021 |
| FY2020 | Dec 31, 2017 | $1.97B | Mar 31, 2021 |
| FY2019 | Dec 31, 2016 | $2.08B | Mar 30, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | ($408.58M) | Mar 30, 2016 |
| FY2015 | Dec 31, 2014 | ($280.04M) | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | ($108.59M) | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | ($19.13M) | Mar 31, 2014 |
| FY2012 | Dec 31, 2011 | $0 | Mar 29, 2013 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $184.67M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $181.29M | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $247.50M | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | $118.98M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $107.38M | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | $121.39M | Mar 28, 2023 |
| FY2021 | Dec 31, 2019 | $466.02M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $10.53M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $4.75M | Mar 30, 2020 |
| FY2018 | Dec 31, 2016 | $9.75M | Mar 27, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.09B | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $3.17B | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | $3.92B | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $4.42B | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | $4.14B | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $2.14B | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | $1.60B | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.52B | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | $2.47B | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | $2.25B | Mar 30, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 28, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 31, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | 0 | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Mar 28, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Mar 31, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 436.91M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | 437.31M | Mar 30, 2026 |
| FY2024 | Dec 31, 2023 | 437.25M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 437.40M | Mar 28, 2024 |
| FY2022 | Dec 31, 2021 | 437.37M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | 362.00M | Mar 31, 2022 |
| FY2020 | Dec 31, 2019 | 311.21M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 311.38M | Mar 30, 2020 |
| FY2018 | Dec 31, 2017 | 311.58M | Mar 27, 2019 |
| FY2017 | Dec 31, 2016 | 311.82M | Mar 30, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $121.29M | Mar 30, 2026 |
| FY2025 | Dec 31, 2024 | $154.04M | Mar 30, 2026 |
| FY2025 | Dec 31, 2023 | $141.82M | Mar 30, 2026 |
| FY2024 | Dec 31, 2022 | $124.04M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $105.98M | Mar 28, 2024 |
| FY2022 | Dec 31, 2020 | $90.66M | Mar 28, 2023 |
| FY2021 | Dec 31, 2019 | $112.08M | Mar 31, 2022 |
| FY2020 | Dec 31, 2018 | $102.82M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $93.31M | Mar 30, 2020 |